--- title: "Orchestra BioMed Holdings (OBIO) stock and investor profile" url: "https://aibio.space/companies/orchestra-biomed/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO), United States. Listing facts, related biotech companies and news on aibio.space." --- OBIO Orchestra BioMed Holdings, Inc. NASDAQ · United States # Orchestra BioMed Holdings (OBIO) news Orchestra BioMed Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker OBIO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Orchestra BioMed Holdings news We have not published a story on Orchestra BioMed Holdings yet. When there is news, it will appear here. ## Orchestra BioMed Holdings at a glance - **Ticker**: OBIO - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $110.0 million ### Related companies - [enVVeno Medical](https://aibio.space/companies/envveno-medical/) NASDAQ: NVNO - [Odyssey Health](https://aibio.space/companies/odyssey-health/) OTC: ODYY - [Spectral AI](https://aibio.space/companies/spectral-ai/) NASDAQ: MDAI - [GE HealthCare Technologies](https://aibio.space/companies/ge-healthcare-technologies/) NASDAQ: GEHC - [Hyperfine](https://aibio.space/companies/hyperfine/) NASDAQ: HYPR - [Lumexa Imaging Holdings](https://aibio.space/companies/lumexa-imaging/) NASDAQ: LMRI - [RESMED INC](https://aibio.space/companies/resmed/) NYSE: RMD - [LogicMark](https://aibio.space/companies/logicmark/) OTC: LGMK ### Also on NASDAQ - [Vera Therapeutics](https://aibio.space/companies/vera-therapeutics/) VERA - [Aardvark Therapeutics](https://aibio.space/companies/aardvark-therapeutics/) AARD - [Imunon](https://aibio.space/companies/imunon/) IMNN - [First Tracks Biotherapeutics](https://aibio.space/companies/first-tracks-biotherapeutics/) TRAX - [Freenome](https://aibio.space/companies/freenome/) FRNM - [Geron](https://aibio.space/companies/geron/) GERN ## Orchestra BioMed Holdings annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$33.5 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | [$2.6 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | | Research and development | [$58.2 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | [$42.8 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | | Net income (loss) | [-$52.7 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | [-$61.0 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | | Cash from operations | [-$49.0 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | [-$50.6 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | | Cash and equivalents | [$34.7 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926093357/) | [$22.3 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | | Short-term investments | [$71.8 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926093357/) | [$44.6 million](https://www.sec.gov/Archives/edgar/data/1814114/000110465926026754/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $20.5 million, plus short-term investments of $89.5 million, $110.0 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Orchestra BioMed Holdings What is the ticker symbol of Orchestra BioMed Holdings? Orchestra BioMed Holdings, Inc. trades under the ticker OBIO on NASDAQ. Where is Orchestra BioMed Holdings listed? Orchestra BioMed Holdings, Inc. is listed on NASDAQ. Which country or territory is Orchestra BioMed Holdings listed under? Our directory records Orchestra BioMed Holdings, Inc. under United States. Does aibio.space cover Orchestra BioMed Holdings? aibio.space lists Orchestra BioMed Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was Orchestra BioMed Holdings's revenue last year? $33.5 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Orchestra BioMed Holdings profitable? Orchestra BioMed Holdings, Inc. reported a net loss of $52.7 million for the fiscal year ended Dec 31, 2025, and used $49.0 million of cash in operations, per its annual report to the SEC. How much does Orchestra BioMed Holdings spend on research and development? $58.2 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Orchestra BioMed Holdings have? $110.0 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: Orchestra BioMed Holdings Members talk about Orchestra BioMed Holdings (OBIO). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:OBIO on TradingView](https://www.tradingview.com/symbols/NASDAQ-OBIO/). ## Listing details Orchestra BioMed Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker OBIO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Orchestra BioMed Holdings, Inc. - **Ticker**: OBIO - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/orchestra-biomed/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Orchestra BioMed Holdings (OBIO) stock and investor profile", 2026-10-31, https://aibio.space/companies/orchestra-biomed/